|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/18 | (2006.01) |
| A61P 7/00 | (2006.01) | ||
| C07K 16/40 | (2006.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K 16/46 | (2006.01) |
| (11) | Number of the document | 3914617 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20708762.8 |
| Date of filing the European patent application | 2020-01-24 | |
| (97) | Date of publication of the European application | 2021-12-01 |
| (45) | Date of publication and mention of the grant of the patent | 2024-03-13 |
| (46) | Date of publication of the claims translation | 2024-05-27 |
| (86) | Number | PCT/US2020/014998 |
| Date | 2020-01-24 |
| (87) | Number | WO 2020/154626 |
| Date | 2020-07-30 |
| (30) | Number | Date | Country code |
| 201962796953 P | 2019-01-25 | US |
| (72) |
PAYTON, Lori , US
MIX, Christian , US
PRADHAN, Rajendra , US
DAMOKOSH, Andrew , US
SWENSON, Eugene Scott , US
GAO, Xiang , US
|
| (73) |
Alexion Pharmaceuticals, Inc. ,
121 Seaport Boulevard, Boston, MA 02210,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Antikūnų prieš C5 dozavimas ir vartojimas gydant atipinį hemolizinį ureminį sindromą (AHUS) |
| DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) |
| Payment date | Validity (years) | Amount | |
| 2024-12-31 | 6 | 139.00 EUR |
| 2026-01-24 |